Manulife (Manufacturers Life Insurance)’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.12M | Sell |
166,386
-73,709
| -31% | -$2.71M | 0.01% | 1075 |
|
2025
Q1 | $8.49M | Buy |
240,095
+2,556
| +1% | +$90.4K | 0.01% | 917 |
|
2024
Q4 | $10.4M | Buy |
237,539
+24,698
| +12% | +$1.08M | 0.01% | 867 |
|
2024
Q3 | $9.65M | Buy |
212,841
+473
| +0.2% | +$21.5K | 0.01% | 905 |
|
2024
Q2 | $8.24M | Buy |
212,368
+13,318
| +7% | +$517K | 0.01% | 913 |
|
2024
Q1 | $6.42M | Buy |
199,050
+20,063
| +11% | +$647K | 0.01% | 1082 |
|
2023
Q4 | $5.13M | Buy |
178,987
+23,451
| +15% | +$673K | ﹤0.01% | 1161 |
|
2023
Q3 | $4.31M | Buy |
155,536
+18,204
| +13% | +$504K | ﹤0.01% | 1186 |
|
2023
Q2 | $3.67M | Buy |
137,332
+1,958
| +1% | +$52.4K | ﹤0.01% | 1221 |
|
2023
Q1 | $2.93M | Buy |
135,374
+41,980
| +45% | +$909K | ﹤0.01% | 1282 |
|
2022
Q4 | $2.24M | Buy |
93,394
+4,796
| +5% | +$115K | ﹤0.01% | 1354 |
|
2022
Q3 | $1.74M | Buy |
88,598
+4,729
| +6% | +$92.7K | ﹤0.01% | 1420 |
|
2022
Q2 | $1.61M | Buy |
83,869
+597
| +0.7% | +$11.5K | ﹤0.01% | 1475 |
|
2022
Q1 | $2.13M | Buy |
83,272
+52,428
| +170% | +$1.34M | ﹤0.01% | 1485 |
|
2021
Q4 | $784 | Buy |
30,844
+404
| +1% | +$10 | ﹤0.01% | 1988 |
|
2021
Q3 | $837K | Sell |
30,440
-2,488
| -8% | -$68.4K | ﹤0.01% | 1958 |
|
2021
Q2 | $1.05M | Buy |
32,928
+9,496
| +41% | +$301K | ﹤0.01% | 1971 |
|
2021
Q1 | $1.08M | Buy |
23,432
+974
| +4% | +$44.7K | ﹤0.01% | 1831 |
|
2020
Q4 | $889K | Buy |
22,458
+1,710
| +8% | +$67.7K | ﹤0.01% | 1886 |
|
2020
Q3 | $722K | Buy |
20,748
+12,246
| +144% | +$426K | ﹤0.01% | 1811 |
|
2020
Q2 | $260K | Buy |
+8,502
| New | +$260K | ﹤0.01% | 2348 |
|